10 Einträge gefunden

1. Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients

   1. Tsourlakis, Maria-Christina
   2. Stender, Annegret
   3. Quaas, Alexander
   4. Kluth, Martina
   5. Wittmer, Corinna
   6. Haese, Alexander
   7. Graefen, Markus

   2016 - Forschungsinformationssystem des UKE - frei zugänglich
2. HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

   1. Zabalza, Cristina Villares
   2. Adam, Meike
   3. Burdelski, Christoph
   4. Wilczak, Waldemar
   5. Wittmer, Corinna
   6. Kraft, Stefan
   7. Krech, Till

   2015 - Forschungsinformationssystem des UKE
3. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

   1. Burdelski, Christoph
   2. Menan, Devi
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Melling, Nathaniel
   7. Minner, Sarah

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
4. VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

   1. Tsourlakis, Maria Christina
   2. Khosrawi, Puya
   3. Weigand, Philipp
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
5. Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

   1. Burdelski, Christoph
   2. Reiswich, V.
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2015 - Forschungsinformationssystem des UKE
6. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

   1. Melling, Nathaniel
   2. Thomsen, Erik
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE
7. Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers

   1. Burdelski, Christoph
   2. Barreau, Ysé
   3. Simon, Ronald
   4. Hube-Magg, Claudia
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2015 - Forschungsinformationssystem des UKE
8. A Feasible and Time-efficient Adaptation of NeuroSAFE for da Vinci Robot-assisted Radical Prostatectomy

   1. Beyer, Burkhard
   2. Schlomm, Thorsten
   3. Tennstedt, Pierre
   4. Boehm, Katharina
   5. Adam, Meike
   6. Schiffmann, Jonas
   7. Sauter, Guido

   2014 - Forschungsinformationssystem des UKE
9. TMPRSS2-ERG Fusions Are Strongly Linked to Young Patient Age in Low-grade Prostate Cancer

   1. Steurer, Stefan
   2. Mayer, Pascale Sophia
   3. Adam, Meike
   4. Krohn, Antje
   5. Koop, Christina
   6. Ospina-Klinck, Daniel
   7. Tehrani, Ali Attarchi

   2014 - Forschungsinformationssystem des UKE
10. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.

    1. Minner, Sarah Jane Pauline
    2. Wittmer, Corinna
    3. Graefen, Markus
    4. Salomon, Georg
    5. Steuber, Thomas
    6. Haese, Alexander
    7. Huland, Hartwig

    2011 - Forschungsinformationssystem des UKE